Matthew Norton

Matthew Norton serves as a General Partner at Ampersand Capital Partners since September 2025, following a distinguished career at Cinven as a Partner in the Investment Team focusing on Healthcare from February 2010 to September 2025. Additional non-executive director roles include positions at BioAgilytix, LGC, and STADA Group between 2020 and 2025, with a specific involvement as Non-Executive Director of Nidda Healthcare. Prior to these, Matthew Norton contributed to Medpace as a Non-Executive Director and worked in M&A at Citi from 2007 to 2010. Matthew Norton holds an MSci in Physics from Imperial College London, earned between 2003 and 2007, and completed education at Haberdashers' Boys' School.